Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI and peer coaches curb opioid overdose deaths in black and latinx communities?

NCT ID NCT06573476

Disease control Sponsor: Friends Research Institute, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to reduce racial disparities in opioid overdose deaths by training peer recovery coaches and using an AI-driven texting tool. The coaches will send personalized texts to participants (Black and Latinx adults with opioid use disorder) to help them connect with treatment and social services. The pilot will test whether this approach is feasible and effective in a small group of 180 people in New York City.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peer recovery coach support and AI-driven text messages
What this could lead to
If successful, this approach could improve access to opioid treatment and social services for Black and Latinx communities, potentially reducing overdose deaths.
What could go wrong
This is a small pilot study (180 people) testing feasibility, not effectiveness. The intervention is behavioral and may not work for everyone. Results may not apply outside New York City.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥18 years of age * fluent in English * self-reported non-prescription opioid use \<30 days prior to consent * provision of informed consent * planned stay in NYC ≥3 months * Black and/or Latinx race/ethnicity * positive urine toxicology for opioids per EMR records or study staff administered random saliva drug testing * diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) * self-reported interest in initiating buprenorphine in primary care, or elsewhere. Exclusion Criteria: * inability to comprehend text content written at a 3rd grade reading level * physical or visual disability preventing mobile phone use

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid-use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid-use disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • START Treatment and Recovery

    RECRUITING

    New York, New York, 11238, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.